Literature DB >> 26776051

Nanotechnology for delivery of peptide nucleic acids (PNAs).

Anisha Gupta1, Raman Bahal1, Meera Gupta2, Peter M Glazer3, W Mark Saltzman4.   

Abstract

Over the past three decades, peptide nucleic acids have been employed in numerous chemical and biological applications. Peptide nucleic acids possess enormous potential because of their superior biophysical properties, compared to other oligonucleotide chemistries. However, for therapeutic applications, intracellular delivery of peptide nucleic acids remains a challenge. In this review, we summarize the progress that has been made in delivering peptide nucleic acids to intracellular targets. In addition, we emphasize recent nanoparticle-based strategies for efficient delivery of conventional and chemically-modified peptides nucleic acids.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antisense therapy; Gene editing; Nanoparticles; Peptide nucleic acids

Mesh:

Substances:

Year:  2016        PMID: 26776051      PMCID: PMC5016210          DOI: 10.1016/j.jconrel.2016.01.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  119 in total

1.  High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

Authors:  Dongmei Cun; Ditte Krohn Jensen; Morten Jonas Maltesen; Matthew Bunker; Paul Whiteside; David Scurr; Camilla Foged; Hanne Mørck Nielsen
Journal:  Eur J Pharm Biopharm       Date:  2010-11-18       Impact factor: 5.571

Review 2.  Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.

Authors:  Rachel K O'Reilly; Craig J Hawker; Karen L Wooley
Journal:  Chem Soc Rev       Date:  2006-10-02       Impact factor: 54.564

3.  Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery.

Authors:  Kohei Tahara; Takeshi Sakai; Hiromitsu Yamamoto; Hirofumi Takeuchi; Yoshiaki Kawashima
Journal:  Int J Pharm       Date:  2007-11-09       Impact factor: 5.875

Review 4.  Acute lung injury: epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth R Johnson; Michael A Matthay
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

5.  A simple cytosine to G-clamp nucleobase substitution enables chiral gamma-PNAs to invade mixed-sequence double-helical B-form DNA.

Authors:  Venugopal Chenna; Srinivas Rapireddy; Bichismita Sahu; Cristina Ausin; Enrique Pedroso; Danith H Ly
Journal:  Chembiochem       Date:  2008-10-13       Impact factor: 3.164

Review 6.  Small molecule compounds targeting miRNAs for cancer therapy.

Authors:  Paloma Del C Monroig; Lu Chen; Shuxing Zhang; George A Calin
Journal:  Adv Drug Deliv Rev       Date:  2014-09-17       Impact factor: 15.470

7.  Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.

Authors:  S H Kang; M J Cho; R Kole
Journal:  Biochemistry       Date:  1998-05-05       Impact factor: 3.162

8.  Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair.

Authors:  G Wang; M M Seidman; P M Glazer
Journal:  Science       Date:  1996-02-09       Impact factor: 47.728

Review 9.  Structure-based DNA-targeting strategies with small molecule ligands for drug discovery.

Authors:  Jia Sheng; Jianhua Gan; Zhen Huang
Journal:  Med Res Rev       Date:  2013-04-30       Impact factor: 12.944

10.  The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

Authors:  Yogesh B Patil; Suresh K Swaminathan; Tanmoy Sadhukha; Linan Ma; Jayanth Panyam
Journal:  Biomaterials       Date:  2009-10-01       Impact factor: 12.479

View more
  19 in total

Review 1.  Reductionist Approach in Peptide-Based Nanotechnology.

Authors:  Ehud Gazit
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

2.  Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging.

Authors:  Makan Khoshnejad; Colin F Greineder; Katherine W Pulsipher; Carlos H Villa; Burcin Altun; Daniel C Pan; Andrew Tsourkas; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  Bioconjug Chem       Date:  2018-02-19       Impact factor: 4.774

3.  Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.

Authors:  Shipra Malik; Vikas Kumar; Chung-Hao Liu; Kuo-Chih Shih; Susan Krueger; Mu-Ping Nieh; Raman Bahal
Journal:  Adv Funct Mater       Date:  2021-11-05       Impact factor: 18.808

4.  Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.

Authors:  Karishma Dhuri; Ravinder Reddy Gaddam; Ajit Vikram; Frank J Slack; Raman Bahal
Journal:  Cancer Res       Date:  2021-09-21       Impact factor: 12.701

5.  Improved i.p. drug delivery with bioadhesive nanoparticles.

Authors:  Yang Deng; Fan Yang; Emiliano Cocco; Eric Song; Junwei Zhang; Jiajia Cui; Muneeb Mohideen; Stefania Bellone; Alessandro D Santin; W Mark Saltzman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

6.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

Review 7.  State-of-the-art progress of switch fluorescence biosensors based on metal-organic frameworks and nucleic acids.

Authors:  Ya-Peng Huo; Sha Liu; Zhi-Xian Gao; Bao-An Ning; Yu Wang
Journal:  Mikrochim Acta       Date:  2021-04-21       Impact factor: 5.833

8.  Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy.

Authors:  Karishma Dhuri; Rutesh N Vyas; Leslie Blumenfeld; Rajkumar Verma; Raman Bahal
Journal:  Cells       Date:  2021-04-25       Impact factor: 7.666

9.  Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria.

Authors:  Kristen A Eller; Thomas R Aunins; Colleen M Courtney; Jocelyn K Campos; Peter B Otoupal; Keesha E Erickson; Nancy E Madinger; Anushree Chatterjee
Journal:  Commun Biol       Date:  2021-03-12

Review 10.  Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.

Authors:  Elias Quijano; Raman Bahal; Adele Ricciardi; W Mark Saltzman; Peter M Glazer
Journal:  Yale J Biol Med       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.